Results 91 to 100 of about 4,080 (215)

Peri-implant MRONJ [PDF]

British Dental Journal, 2020
openaire   +2 more sources

Pharmacology: MRONJ risk factor [PDF]

British Dental Journal, 2018
D, Patel, V, Patel
openaire   +2 more sources

Cause of tooth extraction and development of MRONJ.

, 2018
Cause of tooth extraction and development of MRONJ.
Saki Hayashida (5563316), Souichi Yanamoto (5563325), Masahiro Umeda (366692), Yuki Sakamoto (325900), Madoka Funahara (5563319), Sakiko Soutome (5563313), Yuka Kojima (5563322)   +6 more
core   +1 more source

Nonoperative therapy in stage i mronj: is really an appropriate option?

Background. The best treatment option for early-stage le- sions in medication-related osteonecrosis of the jaw (MRONJ) remain controversial. Operative therapy (segmental or margin- al resection of the mandible and partial maxillectomy) are ef ...
Cargini Pasqualino, Benfatto Silvia, Ascani Giuliano, Mancini Paolo, Romano Michele, Catanzaro Susanna, Rexhep Tari Sergio, Scarano Antonio   +7 more
core  

PREVALENCE OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN PATIENTS TREATED WITH ANTIRESORPTIVES TO PREVENT CANCER TREATMENT-INDUCED BONE LOSS: RETROSPECTIVE LONGITUDINAL STUDY.

openINTRODUZIONE: I pazienti affetti da tumori ormonoresponsivi (seno e prostata), in corso di terapia endocrina adiuvante, possono sviluppare una condizione benigna chiamata cancer treatment-induced bone loss (CTIBL).
ROCCUZZO, FRANCESCA
core  

Is periodontal disease a risk factor for the development of MRONJ?

, 2015
Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious complication for patients undertaking treatment with antiresorptive or antiangiogenic agents.
Danny Watts, Watts, Danny
core   +1 more source

Mesenchymal Stem Cells in Socket Healing and MRONJ

Orthodontics & Craniofacial Research
ABSTRACT This review aims to summarise the current understanding of the biological processes involved in socket healing after tooth extraction and the contribution of mesenchymal stem/progenitor cells (MSCs) during these processes. Additionally, it seeks to explore the mechanisms underlying medication‐related osteonecrosis of the jaw (
Yuki Arai, Chiaki Tsutsumi‐Arai, Jeryl D. English, Noriaki Ono, Wanida Ono   +4 more
openaire   +3 more sources

Dental Risk Assessment and Preventive Management prior to ONJ-related drug therapies: an evidence-based approach

reservedIntroduzione: l’osteonecrosi delle ossa mascellari farmaco-relata (MRONJ) è una grave complicanza che può presentarsi in pazienti che assumono determinate categorie di farmaci, come antiriassorbitivi e antiangiogenetici.
CAPRARO, VITTORIA GIORGIA
core  

Awareness Of Medication-Related Osteonecrosis Of The Jaw (MRONJ) Among Oncology Dental Patients With Risk Factors For MRONJ

, 2016
Introduction: Medication related osteonecrosis of the jaw (MRONJ) is exposed bone in the maxillofacial region that does not heal within eight weeks after identification by a health professional. Cancer patients taking or who have a history of taking anti-
Al Abdullateef, Abdulrhman Y.
core  

Survey of Dentists’ Knowledge Regarding Medication-Related Osteonecrosis of the Jaws.

Batna Journal of Medical Sciences
Objective: To evaluate the knowledge of dentists regarding medication-related osteonecrosis of the jaws (MRONJ) in the municipality of Annaba.
Meriem TAGUIA, Razika SALAH MARS
doaj   +1 more source